Patents by Inventor Anders Weber

Anders Weber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250057451
    Abstract: A system and method of calibrating a model used in a device for non-invasive in vivo measurement of an analyte concentration using Raman spectroscopy, the device including an optical source for providing an optical signal and an optical detector to receive a Raman scattered optical output, the method including: in response to the laser source being directed to a user's skin gathering Raman scattered radiation from the user's skin and based on that, calibrating the model based on reference data and the received Raman spectra over an extended period of days, such as 10 days or more.
    Type: Application
    Filed: October 12, 2022
    Publication date: February 20, 2025
    Inventors: Signe Maria LUNDSGAARD-NIELSEN, Anders PORS, Anders WEBER
  • Patent number: 10433775
    Abstract: A metabolite concentration is measured in vivo using Raman spectroscopy in such a way as to receive at a detector light scattered from the metabolite in interstitial fluid in skin in a measurement location at a depth of from 200-300 ?m below the skin surface providing improved retention of correct calibration and transferability of calibration between individual subjects.
    Type: Grant
    Filed: June 14, 2016
    Date of Patent: October 8, 2019
    Assignee: RSP SYSTEMS A/S
    Inventors: Morten Henneberg, Stefan Ovesen Banke, Anders Weber
  • Publication number: 20160287147
    Abstract: A metabolite concentration is measured in vivo using Raman spectroscopy in such a way as to receive at a detector light scattered from the metabolite in interstitial fluid in skin in a measurement location at a depth of from 200-300 ?m below the skin surface providing improved retention of correct calibration and transferability of calibration between individual subjects.
    Type: Application
    Filed: June 14, 2016
    Publication date: October 6, 2016
    Applicant: RSP SYSTEMS A/S
    Inventors: Morten HENNEBERG, Stefan Ovesen BANKE, Anders WEBER
  • Patent number: 9380942
    Abstract: A metabolite concentration is measured in vivo using Raman spectroscopy in such a way as to receive at a detector (229) light scattered from the metabolite in interstitial fluid in skin in a measurement location (217) at a depth (218) of from 200-300 ?m below the skin surface providing improved retention of correct calibration and transferability of calibration between individual subjects.
    Type: Grant
    Filed: July 5, 2012
    Date of Patent: July 5, 2016
    Assignee: RSP SYSTEMS A/S
    Inventors: Morten Henneberg, Stefan Ovesen Banke, Anders Weber
  • Publication number: 20130018237
    Abstract: A metabolite concentration is measured in vivo using Raman spectroscopy in such a way as to receive at a detector (229) light scattered from the metabolite in interstitial fluid in skin in a measurement location (217) at a depth (218) of from 200-300 ?m below the skin surface providing improved retention of correct calibration and transferability of calibration between individual subjects.
    Type: Application
    Filed: July 5, 2012
    Publication date: January 17, 2013
    Applicant: RSP SYSTEMS A/S
    Inventors: Morten HENNEBERG, Stefan Ovesen Banke, Anders Weber
  • Patent number: 6671527
    Abstract: An assay implantation apparatus is provided comprising a sensor for use for the in vivo measurement of an analyte and means for implanting said sensor within an upper layer of the skin from which it is naturally ejected over time by growth of the skin and progressive replacement of the outer layer of the skin. The sensor may comprise microparticles containing a chemical assay system into which an analyte may diffuse from intercellular fluid and which assay system can be interrogated remotely by a light signal and a fluorescence sensor.
    Type: Grant
    Filed: October 12, 2001
    Date of Patent: December 30, 2003
    Assignee: Precisense A/S
    Inventors: Bo Petersson, Anders Weber
  • Patent number: 6625479
    Abstract: An implantable sensor for use in the detection or quantitative measurement of an analyte in subcutaneous fluid, the sensor being biodegradable or hydrolysable in vivo. The sensor incorporates an assay for the analyte, the readout of which is a detectable or measurable optical signal which can, when the sensor is in operation in a subcutaneous location, be interrogated transcutaneously by external optical means.
    Type: Grant
    Filed: October 1, 2001
    Date of Patent: September 23, 2003
    Assignee: Torsana Diabetes Diagnostics A/S
    Inventors: Anders Weber, Christopher J. Stanley
  • Publication number: 20020058863
    Abstract: An assay implantation apparatus is provided comprising a sensor for use for the in vivo measurement of an analyte and means for implanting said sensor within an upper layer of the skin from which it is naturally ejected over time by growth of the skin and progressive replacement of the outer layer of the skin.
    Type: Application
    Filed: October 12, 2001
    Publication date: May 16, 2002
    Inventors: Bo Petersson, Anders Weber
  • Patent number: 6163714
    Abstract: An implantable sensor for use in the detection or quantitative measurement of an analyte in subcutaneous fluid, the sensor being biodegradable or hydrolysable in vivo. The sensor incorporates an assay for the analyte, the readout of which is a detectable or measurable optical signal which can, when the sensor is in operation in a subcutaneous location, be interrogated transcutaneously by external optical means.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: December 19, 2000
    Assignee: Torsana Diabetes Diagnostics A/S
    Inventors: Christopher John Stanley, Anders Weber
  • Patent number: RE38525
    Abstract: An implantable sensor for use in the detection of quantitative measurement of an analyte in subcutaneous fluid, the sensor being biodegradable or hydrolysable in vivo. The sensor incorporates an assay for the analyte, the readout of which is a detectable or measurable optical signal which can, when the sensor is in operation in a subcutaneous location, be interrogated transcutaneously by external optical means.
    Type: Grant
    Filed: October 23, 2002
    Date of Patent: June 8, 2004
    Assignee: Torsana Diabetes Diagnostics A/S
    Inventors: Christopher John Stanley, Anders Weber